Thomas Shrader Profile - BTIG Analyst

130 Followers
Thomas Shrader

Thomas Shrader
BTIG

Wall Street Analyst
#6,185 out of 8,379 Wall Street Analysts
#19,401 out of 33,343 experts

Success Rate

35%
126 out of 364 transactions made a profit

Average Return

-0.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Thomas Shrader's trades since 2015 and holding each position for 1 Year would result in 34.62% of your transactions generating a profit, with an average return of -0.7% per rating.

Stock Rating Distribution

511Ratings
83.37% Buy
16.63% Hold
0.00% Sell
Distribution of Thomas Shrader's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market

Best Rating

Stock:
AnaptysBio
(ANAB)
Rating:Buy
Date:Feb 21, 2017 - Feb 21, 2018
Return:+410.10%
The most profitable rating made by Thomas Shrader

Thomas Shrader's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Gilead Sciences
Mar 23, 2015
Hold
Downgraded
1Ratings
0.00%
Marinus
Jun 13, 2016
Hold
Downgraded
1Ratings
0.00%
MDVN
Medivation
Aug 23, 2016
Hold
Downgraded
3Ratings
100%
+27.60%
VTAE
Vitae Pharma
Sep 14, 2016
Hold
Downgraded
5Ratings
67%
+78.57%
Molecular Templates
Nov 07, 2016
Hold
Reiterated
$4.40
(831.02% Upside)
3Ratings
0.00%
Eledon Pharmaceuticals
Dec 22, 2016
Hold
Reiterated
$10.80
(459.59% Upside)
4Ratings
0.00%
Arcturus Therapeutics
Jan 17, 2017
Hold
Reiterated
$10.50
(-60.94% Downside)
1Ratings
0.00%
ARGSQ
Argos Therapeutics
May 11, 2017
Hold
Reiterated
6Ratings
0%
-79.93%
Clovis Oncology
Jun 19, 2017
Buy
Reiterated
$125.00
16Ratings
90%
+142.45%
FibroGen
Jun 21, 2017
Buy
Reiterated
$38.00
(112.53% Upside)
9Ratings
89%
+104.22%
List of latest recommendations made by Thomas Shrader. Click to expand and see Thomas Shrader's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Thomas Shrader activity FAQ

What is the performance of Thomas Shrader's recommendations?
The percentage of profitable recommendations made by Thomas Shrader is 35%, and the average return per transaction is -0.70%.
    What stocks does Thomas Shrader cover?
    Thomas Shrader mostly covers BIIB , KITE , ESPR stocks.
      What was Thomas Shrader’s latest rating?
      Thomas Shrader latest rating was a hold on WINT with a price target of $6.00, which represents an Upside of 331.65%
        What was Thomas Shrader's most profitable rating?
        Thomas Shrader’s most profitable ratings was a buy on ANAB stock on Feb 21, 2017 - Feb 21, 2018. The return on the trade was +410.10%.
          Where can i see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here